News and Announcements
Reckoon announces Blockchain based Global WishBasket Shopping Protocol (GloWS)
- Published January 31, 2020 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Reckoon is shaping the future of the retail industry by providing Blockchain & AI Based Global Shopping Platform as a Service.
At the core of our End-to-End shopping ecosystem is the Global WishBasket Shopping Protocol (GloWS), providing a standardised and universal way to fulfil the shoppers WishBasket.
Reckoon is simplifying and integrating the blockchain advantage into mainstream industry.
About Reckoon
Reckoon is a Blockchain-based, One-Stop-Shopping-App, a global shopping ecosystem focused primarily on Gen Z and millennials. This will disrupt the current retail market and engage shoppers through the gamification of worldwide shopping. It will provide global reach to local brands and hyper-local exposure to global brands.
Company Updates
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Backed By Leading Investment Groups and Family Offices
